The Dry Powder Inhaler Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Dry Powder Inhaler Market:
https://www.thebusinessresearchcompany.com/report/dry-powder-inhaler-global-market-report
According to The Business Research Company’s Dry Powder Inhaler Global Market Report 2024, The dry powder inhaler market size has grown strongly in recent years. It will grow from $20.18 billion in 2023 to $21.25 billion in 2024 at a compound annual growth rate (CAGR) of 5.3%. The growth in the historic period can be attributed to renewed interest in sustainable building materials, cultural preservation and heritage restoration, rise in green building practices, local sourcing and community involvement, regulatory support and building codes.
The dry powder inhaler market size is expected to see steady growth in the next few years. It will grow to $25.82 billion in 2028 at a compound annual growth rate (CAGR) of 5.0%. The growth in the forecast period can be attributed to continued emphasis on sustainability, global urbanization trends, advancements in manufacturing processes, government incentives and policies, global economic factors. Major trends in the forecast period include increased research and development, renewed interest in traditional building techniques, advancements in material technology, architectural and design trends, regulatory support for sustainable construction.
The growing prevalence of respiratory diseases is expected to propel the growth of the dry powder inhaler market going forward. Respiratory diseases refer to respiratory disorders or lung diseases, encompassing a broad category of medical conditions affecting the respiratory system. Dry powder inhalers are essential in treating respiratory conditions such as asthma, COPD, and cystic fibrosis as they deliver medicine directly to the lungs, where it is most effective. It is a promising alternative to traditional drug delivery methods for respiratory diseases. For instance, in June 2023, according to reports published by the Australian Institute of Health and Welfare, an Australia-based national agency, there was a rise in respiratory disease-related deaths from 43,031 in 2020 to 46,551 in 2021 in Australia. Therefore, the growing prevalence of respiratory diseases will drive the growth of the dry powder inhaler market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=13430&type=smp
The dry powder inhaler market covered in this report is segmented –
1) By Product: Single-Dose Inhalers, Multi-Dose Inhalers
2) By Function: Manually Operated Inhaler Devices, Digitally Operated Inhaler Devices
3) By Application: Asthma, Chronic Obstructive Pulmonary Disease (COPD), Cystic Fibrosis, Other Applications
4) By End User: Hospitals And Clinics, Homecare Settings, Ambulatory Surgical Centers, Other End Users
Major companies operating in the dry powder inhaler market are developing innovative products with muscarinic antagonist for treating chronic obstructive pulmonary disease (COPD) and expanding their product portfolio. A muscarinic antagonist is a drug that inhibits the muscarinic acetylcholine receptor. It controls and treats various illnesses, such as COPD and organophosphate poisoning. For instance, in June 2021, Glenmark Pharmaceuticals Limited, an India-based pharmaceutical company, launched Tiogiva, a long-acting muscarinic antagonist dry powder inhaler (DPI) that is used to treat chronic obstructive pulmonary disease (COPD) in the UK. It is the bioequivalent generic version of Boehringer-Ingelheim's Spiriva Handihaler. It functions by calming the muscles in the airways, which facilitates breathing. It is taken once a day and is indicated for the long-term maintenance treatment of COPD in adults. Moreover, it is easy to use and does not require a spacer.
The dry powder inhaler market report table of contents includes:
- Executive Summary
- Dry Powder Inhaler Market Characteristics
- Dry Powder Inhaler Market Trends And Strategies
- Dry Powder Inhaler Market- Macro Economic Scenario
- Global Dry Powder Inhaler Market Size and Growth
.
.
.
- Global Dry Powder Inhaler Market Competitive Benchmarking
- Global Dry Powder Inhaler Market Competitive Dashboard
- Key Mergers And Acquisitions In Dry Powder Inhaler Market
- Dry Powder Inhaler Market Future Outlook and Potential Analysis
- Appendix
Top Major Players :
- Novartis AG
- AstraZeneca plc.
- GlaxoSmithKline PLC
- 3M Company
- Boehringer Ingelheim GmbH
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Pulmonary drug delivery has been gaining attention and acceptance in the past few years in the treatment of respiratory disorders due to advantages such as faster drug absorption, high bioavailability, and local action of the drug in the respiratory tract, allowing faster treatment and quick relief to patients suffering from respiratory disorders.
This has induced manufacturers to enter the dry powder inhalers segment, offering a wide range of products to patients suffering from respiratory disorders.Request Brochure –https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=30638 The global dry powder inhalers market can be segmented based on product type, indication, distribution channel, and region.
In terms of product type, the global market can be categorized into capsule based devices, blister based devices, reservoir/cartridge based devices, and others.
The capsule based devices segment is expected to dominate the global dry powder inhalers market during the forecast period, owing to increase in number of manufacturers offering diverse products in the segment and rise in adoption and preference of health care providers and patients for these devices.
Based on indication, the global dry powder inhalers market can be classified into bronchitis, chronic obstructive pulmonary diseases (COPD), asthma, and others.
The asthma segment accounted for the largest share of the global market in 2016, owing to increase in air pollution levels across the world and rise in incidence of asthma especially in developed countries.
Latest added Global Dry Dairy Powder Market research study by AMA Research offers detailed outlook and elaborates market review till 2026.
At present, the market players are strategizing and overcoming challenges of current scenario; The study explored is a perfect mix of qualitative and quantitative Market data collected and validated majorly through primary data and secondary sources.
Increasing demand for longer shelf life dairy products and the rising health consciousness among consumers are expected to be some of the major factors aiding into the growth for the market.
However, the market is expected to witness a slight decline in the growth during the next few years but it is again expected to rise with a healthy pace after the COVID-19 pandemic is over.
The Global Dry Dairy Powder segments and Market Data Break Down are illuminated below: by Type (Dry Whey, Dry Buttermilk, Dry Whole Milk, Dry Dairy Blends, Nonfat Dry Milk, Others), Application (Nutritional Foods, Infant Formulas, Confectionaries, Baked Sweet and Savories , Others), Sales Channel (Online, Offline {Hypermarkets) What's Trending in Market:Increase in Use of Milk Powder in Infant Foods Due to the Presence of Several Nutrients such as Vitamin C, Vitamin B12, Thiamin, and High Amount of Protein Challenges:Growing Concerns for Ultra-High Temperature (UHT) Milk Restraints:The Outbreak of COVID-19 Pandemic is one of the Major Restraints for the Market as Most of the Industries have been Facing Economic Crisis Across the World Market Growth Drivers:Increasing Demand for Longer Shelf Life Dairy ProductsRising Health Consciousness Among Consumers The regional analysis of Global Dry Dairy Powder Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World.
North America is the leading region across the world.
The research report includes specific segments by region (country), by manufacturers, by Type and by Application.
Each type provides information about the production during the forecast period of 2016 to 2027. by Application segment also provides consumption during the forecast period of 2016 to 2027.
Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by TypeDownload FREE Sample of this Report @ https://www.grandresearchstore.com/report-sample/global-tocopherols-mixed-2021-734 Liquid OilDry Powder Segment by Application CosmeticsFood and BeverageOther By Company BASFDSMADMMerckMatrix Fine SciencesOrganic TechnologiesZhejiang Zhongxian Biotechnology Production by Region North AmericaEuropeChinaJapan Consumption by Region North AmericaU.S.CanadaEuropeGermanyFranceU.K.ItalyRussiaAsia-PacificChinaJapanSouth KoreaIndiaAustraliaTaiwanIndonesiaThailandMalaysiaPhilippinesVietnamLatin AmericaMexicoBrazilArgentinaMiddle East & AfricaTurkeySaudi ArabiaU.A.EGet the Complete Report & TOC @ https://www.grandresearchstore.com/chemicals-and-materials/global-tocopherols-mixed-2021-734Table of content1 Tocopherols Mixed Market Overview1.1 Product Overview and Scope of Tocopherols Mixed1.2 Tocopherols Mixed Segment by Type1.2.1 Global Tocopherols Mixed Market Size Growth Rate Analysis by Type 2021 VS 20271.2.2 Liquid Oil1.2.3 Dry Powder1.3 Tocopherols Mixed Segment by Application1.3.1 Global Tocopherols Mixed Consumption Comparison by Application: 2016 VS 2021 VS 20271.3.2 Cosmetics1.3.3 Food and Beverage1.3.4 Other1.4 Global Market Growth Prospects1.4.1 Global Tocopherols Mixed Revenue Estimates and Forecasts (2016-2027)1.4.2 Global Tocopherols Mixed Production Capacity Estimates and Forecasts (2016-2027)1.4.3 Global Tocopherols Mixed Production Estimates and Forecasts (2016-2027)1.5 Global Tocopherols Mixed Market by Region1.5.1 Global Tocopherols Mixed Market Size Estimates and Forecasts by Region: 2016 VS 2021 VS 20271.5.2 North America Tocopherols Mixed Estimates and Forecasts (2016-2027)1.5.3 Europe Tocopherols Mixed Estimates and Forecasts (2016-2027)1.5.5 China Tocopherols Mixed Estimates and Forecasts (2016-2027)1.5.5 Japan Tocopherols Mixed Estimates and Forecasts (2016-2027)2 Market Competition by Manufacturers2.1 Global Tocopherols Mixed Production Capacity Market Share by Manufacturers (2016-2021)2.2 Global Tocopherols Mixed Revenue Market Share by Manufacturers (2016CONTACT US:276 5th Avenue, New York , NY 10001,United StatesInternational: (+1) 646 781 7170 / +91 8087042414Follow Us On linkedin :- https://www.linkedin.com/company/grand-research-store/
